Source: Annual Congress 2005 - Diffuse parenchymal lung diseases: experimental animal studies and case reports
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Sengun, C. Gonen, A. Kargi, A. Onen, P. Balci, A. Akkoclu, O. Gonen (Izmir, Turkey). A case of acute interstitial pneumonia which developed during the interferon and ribavirin treatment for chronic hepatitis C. Eur Respir J 2005; 26: Suppl. 49, 626

Member's Comments

No comment yet.

Related content which might interest you: Fatal interstitial pneumonitis in a patient treated with pegylated interferon alpha-2b and ribavirin for hepatitis C infection Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003 Successful hepatitis B treatment with lamivudine and interferon-alpha in a patient with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 617s Year: 2004 Sarcoidosis associated with interferon-α therapy for chronic hepatitis C Source: Eur Respir J 2006; 28: Suppl. 50, 541s Year: 2006 The role of hepatitis C virus infections in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005 Interstitial lung involvement in patients with chronic HCV hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006 Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 The treatment of cough with interferon in adult patients with stable chronic bronchitis Source: Eur Respir J 2003; 22: Suppl. 45, 426s Year: 2003 Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease Source: Eur Respir J 2005; 25: 570-573 Year: 2005 The frequency of respiratory infections in patients with chronic hepatitis C treated with pegylated-Interferon Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007 The prevalence rate of chronic hepatitis B and C among pulmonary TB patients Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008 Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: 496-504 Year: 2006 Non-specific interstitial pneumonia of the pediatric age and recombinant interferon gamma-1b Source: Eur Respir J 2004; 24: Suppl. 48, 717s Year: 2004 Fulminant hepatitis during antituberculosis chemotherapy: five case reports Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005 Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis Source: Eur Respir J 2006; 27: 1307-1310 Year: 2006 Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia Source: Eur Respir J 2015; 45: 1624-1631 Year: 2015 Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy Source: Eur Respir J 2009; 33: 1518-1519 Year: 2009 Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005